These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27696662)

  • 1. Remote Ischemic Conditioning on Recipients of Deceased Renal Transplants Does Not Improve Early Graft Function: A Multicenter Randomized, Controlled Clinical Trial.
    Krogstrup NV; Oltean M; Nieuwenhuijs-Moeke GJ; Dor FJ; Møldrup U; Krag SP; Bibby BM; Birn H; Jespersen B
    Am J Transplant; 2017 Apr; 17(4):1042-1049. PubMed ID: 27696662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote ischaemic conditioning on recipients of deceased renal transplants, effect on immediate and extended kidney graft function: a multicentre, randomised controlled trial protocol (CONTEXT).
    Krogstrup NV; Oltean M; Bibby BM; Nieuwenhuijs-Moeke GJ; Dor FJ; Birn H; Jespersen B
    BMJ Open; 2015 Aug; 5(8):e007941. PubMed ID: 26297360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote ischaemic conditioning and early changes in plasma creatinine as markers of one year kidney graft function-A follow-up of the CONTEXT study.
    Nielsen MB; Krogstrup NV; Oltean M; Nieuwenhuijs-Moeke GJ; Dor FJMF; Birn H; Jespersen B
    PLoS One; 2019; 14(12):e0226882. PubMed ID: 31887168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote ischemic conditioning enhanced the early recovery of renal function in recipients after kidney transplantation: a randomized controlled trial.
    Wu J; Feng X; Huang H; Shou Z; Zhang X; Wang R; Chen Y; Chen J
    J Surg Res; 2014 May; 188(1):303-8. PubMed ID: 24556231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote ischemic conditioning may improve graft function following kidney transplantation: a systematic review and meta-analysis with trial sequential analysis.
    Zhang Y; Long Y; Li Y; Liao D; Hu L; Peng K; Liu H; Ji F; Shan X
    BMC Anesthesiol; 2024 May; 24(1):168. PubMed ID: 38702625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of remote ischemic conditioning on mortality after kidney transplantation: the systematic review and meta-analysis of randomized controlled trials.
    Ko E; Park HY; Lim CH; Kim HJ; Jang Y; Seong H; Kim YH; Shin HJ
    Syst Rev; 2024 Jul; 13(1):201. PubMed ID: 39075595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Remote Ischemic Conditioning on Organ Transplantation: A Meta-Analysis of Randomized Controlled Trials.
    Zhang M; Ma X; Wang X; Zhang C; Zheng M; Ma W; Dai Y
    Transplant Proc; 2024; 56(6):1457-1468. PubMed ID: 38981761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
    Jordan SC; Choi J; Aubert O; Haas M; Loupy A; Huang E; Peng A; Kim I; Louie S; Ammerman N; Najjar R; Puliyanda D; Vo A
    Am J Transplant; 2018 Dec; 18(12):2955-2964. PubMed ID: 29637714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
    Orban JC; Fontaine E; Cassuto E; Baumstarck K; Leone M; Constantin JM; Ichai C;
    Trials; 2018 Apr; 19(1):231. PubMed ID: 29665840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trial.
    Orban JC; Quintard H; Cassuto E; Jambou P; Samat-Long C; Ichai C
    Transplantation; 2015 Apr; 99(4):746-53. PubMed ID: 25250647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials.
    Schröppel B; Akalin E; Baweja M; Bloom RD; Florman S; Goldstein M; Haydel B; Hricik DE; Kulkarni S; Levine M; Mehrotra A; Patel A; Poggio ED; Ratner L; Shapiro R; Heeger PS
    Am J Transplant; 2020 Feb; 20(2):564-572. PubMed ID: 31452319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.
    Huang E; Vo A; Choi J; Ammerman N; Lim K; Sethi S; Kim I; Kumar S; Najjar R; Peng A; Jordan SC
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):109-116. PubMed ID: 31843975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early remote ischaemic preconditioning leads to sustained improvement in allograft function after live donor kidney transplantation: long-term outcomes in the REnal Protection Against Ischaemia-Reperfusion in transplantation (REPAIR) randomised trial.
    Veighey KV; Nicholas JM; Clayton T; Knight R; Robertson S; Dalton N; Harber M; Watson CJE; De Fijter JW; Loukogeorgakis S; MacAllister R
    Br J Anaesth; 2019 Nov; 123(5):584-591. PubMed ID: 31521337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote ischemic preconditioning of transplant recipients to reduce graft ischemia and reperfusion injuries: A systematic review.
    Farooqui W; Pommergaard HC; Rasmussen A
    Transplant Rev (Orlando); 2018 Jan; 32(1):10-15. PubMed ID: 28637593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial.
    Schnuelle P; Gottmann U; Hoeger S; Boesebeck D; Lauchart W; Weiss C; Fischereder M; Jauch KW; Heemann U; Zeier M; Hugo C; Pisarski P; Krämer BK; Lopau K; Rahmel A; Benck U; Birck R; Yard BA
    JAMA; 2009 Sep; 302(10):1067-75. PubMed ID: 19738091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited Clinical Utility of Remote Ischemic Conditioning in Renal Transplantation: A Meta-Analysis of Randomized Controlled Trials.
    Zhou CC; Ge YZ; Yao WT; Wu R; Xin H; Lu TZ; Li MH; Song KW; Wang M; Zhu YP; Zhu M; Geng LG; Gao XF; Zhou LH; Zhang SL; Zhu JG; Jia RP
    PLoS One; 2017; 12(1):e0170729. PubMed ID: 28129389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial.
    Sun Q; Hong L; Huang Z; Na N; Hua X; Peng Y; Zhao M; Cao R; Sun Q
    Trials; 2017 Nov; 18(1):545. PubMed ID: 29145879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed graft function in the kidney transplant.
    Siedlecki A; Irish W; Brennan DC
    Am J Transplant; 2011 Nov; 11(11):2279-96. PubMed ID: 21929642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Complement Pathways During Cold Ischemia and Reperfusion Prevents Delayed Graft Function.
    Yu ZX; Qi S; Lasaro MA; Bouchard K; Dow C; Moore K; Wu Z; Barama A; Xu J; Johnson K; Marozsan AJ; Wang Y
    Am J Transplant; 2016 Sep; 16(9):2589-97. PubMed ID: 27003920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No Effect of Remote Ischemic Conditioning Strategies on Recovery from Renal Ischemia-Reperfusion Injury and Protective Molecular Mediators.
    Kierulf-Lassen C; Kristensen ML; Birn H; Jespersen B; Nørregaard R
    PLoS One; 2015; 10(12):e0146109. PubMed ID: 26720280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.